Discover
COYA
Coya Therapeutics, Inc.
4.95
2 x 3.63
2 x 6.37
bid
ask
-
0.04
0.80%
2 @ 04:00 PM
4.95 +0.00 (0.00%)
| Ytd | -14.66% | |
| 1y | -21.05% |
4.85
day range
5.04
3.78
52 week range
7.36
| Open | 5.00 | Prev Close | 4.99 | Low | 4.85 | High | 5.04 | Mkt Cap | 116.12M |
| Vol | 151.83K | Avg Vol | 158.05K | EPS | -1.06 | P/E | N/A | Forward P/E | -4.25 |
| Beta | 0.58 | Short Ratio | 1.53 | Inst. Own | 19.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-11 | 50-d Avg | 4.75 | 200-d Avg | 4.73 | 1yr Est | 15.50 |
| Income Statement | |||
| Total Revenue | 243.75K | ||
| Revenues (USD) | 243.75K | ||
| Gross Profit | 243.75K | ||
| Operating Expenses | 7.29M | ||
| Research and Development Expense | 5.03M | ||
| Selling, General and Administrative Expense | 2.26M | ||
| Operating Income | -7.05M | ||
| Net Income | -6.64M | ||
| Net Income Common Stock | -6.64M | ||
| Net Income Common Stock (USD) | -6.64M | ||
| Consolidated Income | -6.64M | ||
| Earnings per Basic Share | -0.28 | ||
| Earnings per Basic Share (USD) | -0.28 | ||
| Earnings per Diluted Share | -0.28 | ||
| Earning Before Interest & Taxes (EBIT) | -6.64M | ||
| Earning Before Interest & Taxes (USD) | -6.64M | ||
| Weighted Average Shares | 23.46M | ||
| Weighted Average Shares Diluted | 23.46M | ||
| Balance Sheet | |||
| Cash and Equivalents | 43.18M | ||
| Cash and Equivalents (USD) | 43.18M | ||
| Current Assets | 47.06M | ||
| Property, Plant & Equipment Net | 5.61K | ||
| Total Assets | 47.31M | ||
| Current Liabilities | 3.51M | ||
| Total Liabilities | 4.03M | ||
| Accumulated Retained Earnings (Deficit) | -75.81M | ||
| Shareholders Equity | 43.28M | ||
| Shareholders Equity (USD) | 43.28M | ||
| Assets Non-Current | 250.34K | ||
| Deferred Revenue | 1.75M | ||
| Liabilities Non-Current | 519.64K | ||
| Trade and Non-Trade Payables | 1.09M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.81K | ||
| Net Cash Flow from Financing | -166.07K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -7.54M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -1.66K | ||
| Issuance (Purchase) of Equity Shares | -166.07K | ||
| Net Cash Flow from Investing | -1.66K | ||
| Net Cash Flow from Operations | -7.38M | ||
| Share Based Compensation | 943.91K | ||